Unique ID issued by UMIN | UMIN000046031 |
---|---|
Receipt number | R000052542 |
Scientific Title | Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy |
Date of disclosure of the study information | 2021/12/01 |
Last modified on | 2022/03/21 11:19:07 |
Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy
Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy
Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy
Association of circulating tumor cell gene mutations and peripheral blood lymphocyte telomere length with the frequency and severity of immune-related pneumonitis in lung cancer patients receiving cancer immunotherapy
Japan |
Lung cancer
Medicine in general | Pneumology | Hematology and clinical oncology |
Adult |
Malignancy
YES
To investigate the association between driver gene mutations of circulating tumor DNA (ctDNA) in blood and telomere length of peripheral blood lymphocytes in lung cancer patients and the frequency and severity of immune-related pneumonitis during cancer immunotherapy.
Safety,Efficacy
The frequency and severity of immune-related pneumonitis during cancer immunotherapy.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
The patient who has been histopathologically diagnosed with lung cancer.
The patient who are planning to undergo cancer immunotherapy.
Those who do not consent to the research.
70
1st name | Kohei |
Middle name | |
Last name | Fujita |
National Hospital Organization Kyoto Medical Center
Respiratory Medicine
612-8555
1-1, Fukakusa-Mukaihata, Fushimi-Ku, Kyoto, Japan
0756419161
kfujita.acd@gmail.com
1st name | Kohei |
Middle name | |
Last name | Fujita |
NHO Kyoto Medical Center
Respiratory Medicine
612-8555
1-1, Fukakusa-Mukaihata, Fushimi-Ku, Kyoto, Japan
0756419161
kfujita.acd@gmail.com
NHO Kyoto Medical Center
NHO Kyoto Medical Center
Self funding
Japan
MiRTel Co.,Ltd.
NHO Kyoto Medical Center
1-1, Fukakusa-Mukaihata, Fushimi-Ku, Kyoto, Japan
0756419161
yamaji.hirofumi.bg@mail.hosp.go.jp
NO
国立病院機構京都医療センター
2021 | Year | 12 | Month | 01 | Day |
Unpublished
Open public recruiting
2021 | Year | 11 | Month | 15 | Day |
2021 | Year | 11 | Month | 15 | Day |
2021 | Year | 12 | Month | 01 | Day |
2024 | Year | 12 | Month | 01 | Day |
2025 | Year | 12 | Month | 01 | Day |
2025 | Year | 12 | Month | 01 | Day |
2025 | Year | 12 | Month | 31 | Day |
To investigate the association between driver gene mutations of circulating tumor DNA (ctDNA) in blood and telomere length of peripheral blood lymphocytes in lung cancer patients and the frequency and severity of immune-related interstitial pneumonia during cancer immunotherapy.
2021 | Year | 11 | Month | 10 | Day |
2022 | Year | 03 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052542